Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure / Razvoj samoemulzifirajućeg sustava za isporuku albendazola (SEDDS) s pojačanom sistemskom apsorpcijom

1. J. R. Robinson, Introduction: semi-solid formulations for oral drug delivery, Bull. Tech. Gattefosse 89 (1996) 11-13.Search in Google Scholar

2. A. K. Meena, D. V. Ratnam, G. Chandraiah, D. D. Ankola, P. R. Rao and M. N. Kumar, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia, Lipids 43 (2008) 231-241; DOI: 10.1007/s11745-007-3142-5.10.1007/s11745-007-3142-5Search in Google Scholar

3. D. V. Ratnam, G. Chandraiah, A. K. Meena, P. Ramarao and M. N. Kumar, The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats, J. Nanosci. Nanotechnol. 9 (2009) 6741-6746.10.1166/jnn.2009.1461Search in Google Scholar

4. C. W. Pouton, Effects of the inclusion of a model drug on the performance of self-emulsifying formulations, J. Pharm. Pharmacol. 37 (1985) Suppl. 12:1P; DOI: 10.1111/j.2042-7158.1985.tb14073.Search in Google Scholar

5. C. W. Pouton, Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, Int. J. Pharm. 27 (1985) 335-348; DOI: 10.1016/ 0378-5173(85)90081-X.Search in Google Scholar

6. C. W. Pouton, Formulation of self-emulsifying drug delivery systems, Adv. Drug. Deliv. Rev. 25 (1997) 47-58; DOI: 10.1016/S0169-409X(96)00490-5.10.1016/S0169-409X(96)00490-5Search in Google Scholar

7. H. Shen and M. Zhong, Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin, J. Pharm. Pharmacol. 58 (2006) 1183-1191; DOI: 10.1211/jpp.58.9.0004.10.1211/jpp.58.9.0004Search in Google Scholar

8. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm. 106 (1994) 15-23; DOI: 10.1016/0378-5173(94)90271-2.10.1016/0378-5173(94)90271-2Search in Google Scholar

9. T. R. Kommuru, B. Gurley, M. A. Khan and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, Int. J. Pharm. 212 (2001) 233-246; DOI: 10.1016/ S0378-5173(00)00614-1.Search in Google Scholar

10. A. A. Kale and V. B. Patravale, Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine, AAPS Pharm. Sci. Tech. 9 (2008) 191-196; DOI: 10.1208/s12249-008-9037-9.10.1208/s12249-008-9037-9Search in Google Scholar

11. J. I. Tang, J. Sun and Z. G. He, Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs, Curr. Drug Therapy 2 (2007) 85-93.Search in Google Scholar

12. P. Gao, B. D. Rush, W. P. Pfund, T. Huang, J. M. Bauer W. Morozowich, M. S. Kuo and M. J. Hageman, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability, J. Pharm. Sci. 87 (2003) 2386-2398; DOI: 10.1002/jps.10511.10.1002/jps.10511Search in Google Scholar

13. G. C. Cook, Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy, Parasitol. Today 6 (1990) 133-136; DOI: 10.1016/0169-4758(90)90232-S.10.1016/0169-4758(90)90232-SSearch in Google Scholar

14. E. Galia, J. Horton and J. B. Dressman, Albendazole generics: a comparative in vitro study, Pharm. Res. 16 (1999) 1871-1875; DOI: 10.1023/A:1018907527253.10.1023/A:1018907527253Search in Google Scholar

15. I. M. Rigter, H. G. Schipper, R. P. Koopmans, H. J. M. Van Kan, H. W. Frijlink, P. A. Kager and H. J. Guchelaar, Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers, Antimicrob. Agents Chemother. 48 (2004) 1051-1054; DOI: 10.1128/ AAC. 48.3. 1051-1054.2004.Search in Google Scholar

16. C. T. Dollery, Albendazole, in Therapeutic Drugs, 2nd ed., Churchill Livingstone, Edinburgh 1999, pp. 184-188.Search in Google Scholar

17. J. J. García, F. Bolas and J. J. Torrado, Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole, Int. J. Pharm. 250 (2003) 351-358; DOI: 10.1016/S0378-5173(02)00559-8.10.1016/S0378-5173(02)00559-8Search in Google Scholar

18. S. Torrado, S. Torrado, R. Cadorniga and J. J. Torrado, Formulation parameters of albendazole solution, Int. J. Pharm. 140 (1996) 45-50; DOI: 10.1016/0378-5173(96)04545-0.10.1016/0378-5173(96)04545-0Search in Google Scholar

19. S. Torrado, M. L. López, G. Torrado, F. Bolás, S. Torrado and R. Cadórniga, A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation, Int. J. Pharm. 156 (1997) 181-187; DOI: 10.1016/S0378-5173(97)00204-4.10.1016/S0378-5173(97)00204-4Search in Google Scholar

20. P. A. Redondo, A. I. Alvarez, J. L. García, C. Villaverde and J. G. Prieto, Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats, Biopharm. Drug Dispos. 19 (1998) 65-70.10.1002/(SICI)1099-081X(199801)19:1<65::AID-BDD76>3.0.CO;2-8Search in Google Scholar

21. H. Wen, R. R. New, M. Muhmut, J. H. Wang, Y. H. Wang, J. H. Zhang, Y. M. Shao and P. S. Craig, Pharmacology and efficacy of liposome entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine, Parasitology 113 (1996) 111-121; DOI: 10.1017/S003118200006635X.10.1017/S003118200006635XSearch in Google Scholar

22. S. Torrado, S. Torrado, J. J. Torrado and R. Cadórniga, Preparation, dissolution and characterization of albendazole solid dispersion, Int. J. Pharm. 140 (1996) 247-250; DOI: 10.1016/0378-5173(96)04586-3.10.1016/0378-5173(96)04586-3Search in Google Scholar

23. M. L. Lopez, S. Torrado, S. Torrado, A. R. Martínez and F. Bolás, Improvement of albendazole efficacy against enteral, but not against parenteral stages of Trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone, Chemotherapy 43 (1997) 430-435; DOI: 10.1159/000239602.10.1159/000239602Search in Google Scholar

24. R. Kalaiselvan, G. P. Mohanta, K. Kannan, P. K. Manna and R. Manavalan, Optimization of drug-polymer mixing ratio in albendazole-polyvinylpyrrolidone solid dispersion by moisture absorption studies, Acta. Pharm. Sci. 48 (2006) 141-151.Search in Google Scholar

25. J. A. Castillo, J. Palomo-Canales, J. J. Garcia, J. L. Lastres, F. Bolas and J. J. Torrado, Preparation and characterization of albendazole β-cyclodextrin complexes, Drug. Dev. Ind. Pharm. 25 (1999) 1241-1248; DOI: 10.1081/DDC-100102294.10.1081/DDC-100102294Search in Google Scholar

26. G. Piel, B. Evrard, T. Van Hees, G. Llabres and L. Delattre, Development of a parenteral and of an oral formulation of albendazole with cyclodextrins, STP. Pharma. Sci. 9 (1999) 257-260.Search in Google Scholar

27. T. Mukherjee and F. M. Plakogiannis, Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole, J. Pharm. Pharmacol. 62 (2010) 1112-1120; DOI: 10.1111/j.2042-7158.2010.01149.x.10.1111/j.2042-7158.2010.01149.xSearch in Google Scholar

28. C. W. Pouton, Lipid formulations for oral administration of drugs: non- emulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci. 11 (2000) S93-S98; DOI: 10.1016/S0928-0987(00)00167-6.10.1016/S0928-0987(00)00167-6Search in Google Scholar

29. V. Borhade, H. Nair and D. Hegde, Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus, AAPS Pharm. Sci. Tech. 9 (2008) 13-21; DOI: 10.1208/s12249-007-9014-8.10.1208/s12249-007-9014-8Search in Google Scholar

30. K. Sharma, M. Kandaswamy, C. Mithra, A. K. Meena, S. Giri, S. Rajagopal and R. Mullangi, Highly sensitive LC-MS/MS-ESI method for simultaenous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study, Biomed. Chromatogr. 26 (2011) 247-255; DOI: 10.1002/bmc.1654.10.1002/bmc.165421633966Search in Google Scholar

31. H. Jung, M. Hurtado, M. Sanchez, M. T. Medina and J. Sotelo, Clinical pharmacokinetics of albendazole in patients with brain cysticercosis, J. Clin. Pharmacol. 32 (1992) 28-31.10.1002/j.1552-4604.1992.tb03783.x1740534Search in Google Scholar

32. J. Sotelo and H. Jung, Pharmacokinetic optimization of treatment of neurocysticercosis, Clin. Pharmacokinet. 34 (1998) 503-515.10.2165/00003088-199834060-000069646011Search in Google Scholar